Novadiscovery is a health tech company that develops a hybrid approach combining mechanistic models and artificial intelligence to de-risk research programs and optimize clinical development. It focuses on in silico clinical trials supporting biotech and pharma companies, academic research centers, and not-for-profit organizations.